582 related articles for article (PubMed ID: 12847240)
1. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
2. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
[TBL] [Abstract][Full Text] [Related]
3. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
6. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
7. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
8. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
[TBL] [Abstract][Full Text] [Related]
9. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
11. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
Quinn A; McInerney MF; Sercarz EE
J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
[TBL] [Abstract][Full Text] [Related]
13. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
14. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
[TBL] [Abstract][Full Text] [Related]
15. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
[TBL] [Abstract][Full Text] [Related]
16. T regulatory cells 1 inhibit a Th2-specific response in vivo.
Cottrez F; Hurst SD; Coffman RL; Groux H
J Immunol; 2000 Nov; 165(9):4848-53. PubMed ID: 11046008
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
19. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
[TBL] [Abstract][Full Text] [Related]
20. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]